HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

FR167653 attenuates ischemia and reperfusion injury of the rat lung with suppressing p38 mitogen-activated protein kinase.

AbstractBACKGROUND:
FR167653 is a potent suppressant of tumor necrosis factor (TNF)-alpha and interleukin-1 (IL-1) production, and was shown to attenuate ischemia and reperfusion (I/R) organ injury in our previous experiment. Because p38 mitogen-activated protein (MAP) kinase has been reported to regulate the production of TNF-alpha and IL-1, we examined the effects of FR167653 in the rat lung I/R model and determined the expression and activation of p38 MAP kinase.
METHODS:
Experiment 1: After 1 hour of ischemia, p38 MAP kinase, phosphorylated p38 MAP kinase (active form), histologic changes of the lung, and serum levels of TNF-alpha and IL-1beta were examined. Experiment 2: After 2 hours of reperfusion, arterial oxygen content (PaO(2)) and saturation (SaO(2)), serum TNF-alpha and IL-1beta levels, and histologic changes in the lung were examined. Rats were divided into three groups in Experiment 1. In the control group, a saline solution was administered and, in the FR group, 0.1 mg/kg per hour of FR167653 was administered, intravenously throughout the experiment, beginning 30 minutes before ischemia. In the non-ischemic group, samples were taken soon after thoracotomy. The rats were divided into control and FR groups in Experiment 2.
RESULTS:
Experiment 1: One hour of ischemia induced almost no changes in the lung or serum cytokine levels. Meanwhile, FR167653 markedly attenuated the expression of phosphorylated p38 MAP kinase. Experiment 2: SaO(2) and PaO(2) were improved, serum cytokines were lower, and lung damage was less extensive in the FR group than in the control group.
CONCLUSION:
FR167653 attenuates I/R injury of the lung and this attenuation is associated with suppression of p38 MAP kinase activation.
AuthorsY Kawashima, I Takeyoshi, Y Otani, Y Koibuchi, D Yoshinari, T Koyama, M Kobayashi, K Matsumoto, Y Morishita
JournalThe Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation (J Heart Lung Transplant) Vol. 20 Issue 5 Pg. 568-74 (May 2001) ISSN: 1053-2498 [Print] United States
PMID11343984 (Publication Type: Journal Article)
Chemical References
  • Cytokines
  • FR 167653
  • Immunosuppressive Agents
  • Interleukin-1
  • Pyrazoles
  • Pyridines
  • Tumor Necrosis Factor-alpha
  • Mitogen-Activated Protein Kinases
  • p38 Mitogen-Activated Protein Kinases
Topics
  • Animals
  • Cytokines (drug effects)
  • Immunosuppressive Agents (pharmacology)
  • Interleukin-1 (blood)
  • Ischemia (prevention & control)
  • Lung (blood supply)
  • Male
  • Mitogen-Activated Protein Kinases (analysis, antagonists & inhibitors)
  • Models, Animal
  • Pyrazoles (pharmacology)
  • Pyridines (pharmacology)
  • Rats
  • Rats, Wistar
  • Reperfusion Injury (prevention & control)
  • Tumor Necrosis Factor-alpha (analysis, drug effects)
  • p38 Mitogen-Activated Protein Kinases

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: